Drug recall · October 29, 2025
Bupropion Hydrochloride Extended-Release Tablets USP recall
Why: Failed Tablet/Capsule Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.
- Lots / codes
Batch # BPB124341A, Exp date: 10/2026
- Quantity
- 46,512/30 count bottles
- Company
- Graviti Pharmaceuticals Private Limited, Hyderabad
- Distribution
- Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
- Initiated
- September 15, 2025 · Voluntary: Firm initiated
- Classified
- October 21, 2025
- Reported
- October 29, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupropion
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.